...
首页> 外文期刊>Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation >Acceptability of the Schedule for the Evaluation of Individual Quality of Life-Direct Weight (SEIQoL-DW) in youth with type 1 diabetes.
【24h】

Acceptability of the Schedule for the Evaluation of Individual Quality of Life-Direct Weight (SEIQoL-DW) in youth with type 1 diabetes.

机译:评估1型糖尿病青年个人直接生活质量体重(SEIQoL-DW)时间表的可接受性。

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this study was to assess the acceptability of the Schedule for the Evaluation of Individual Quality of Life-Direct Weight (SEIQoL-DW) in youth with diabetes. This measure asks respondents to assess the importance and satisfaction of domains that they nominate as being important to their own quality of life. Seventy-seven young people (age 8-17 years, M = 12.4) with type 1 diabetes were given the SEIQoL-DW. Data from 10 participants were deemed invalid due to respondents' inability to understand the task. Respondents whose data were deemed invalid were all under 12 years of age, M = 9.3. For participants with valid data, interviewers' ratings of participant boredom and fatigue were low. Time to complete the interview was reasonably short, M = 14.9 min. Of the 335 total QOL domains nominated by participants with valid data, only 19 domains (6%) were nominated with the assistance of a standard list. Forty-five participants nominated 'diabetes' as a life domain. Results indicate the SEIQoL-DW performed well with respondents over 12 years of age, is appropriate for samples with diabetes, and taps into diabetes-relevant domains. Further research with more diverse samples is needed before firm age cut-offs can be established for its use.
机译:这项研究的目的是评估接受评估的青年糖尿病患者个人直接生活质量体重表(SEIQoL-DW)的可接受性。这项措施要求受访者评估他们提名对自己的生活质量至关重要的领域的重要性和满意度。对77位患有1型糖尿病的年轻人(年龄8-17岁,M = 12.4)进行了SEIQoL-DW治疗。由于受访者无法理解任务,因此将10位参与者的数据视为无效。被认为是无效数据的受访者均未满12岁,M = 9.3。对于具有有效数据的参与者,访调员对参与者的无聊和疲劳的评分较低。完成采访的时间相当短,M = 14.9分钟。参与者使用有效数据提名的335个QOL域中,只有19个域(6%)在标准列表的帮助下被提名。四十五名参与者将“糖尿病”提名为生命领域。结果表明,SEIQoL-DW在12岁以上的受访者中表现良好,适用于患有糖尿病的样本,并进入了与糖尿病相关的领域。在确定使用年龄的确切界限之前,需要对更多样本进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号